A novel role of CD30L/CD30 signaling by T-T cell interaction in Th1 response against mycobacterial infection

Ce Tang, Hisakata Yamada, Kensuke Shibata, Hiromi Muta, Worawidh Wajjwalku, Eckhard R. Podack, Yasunobu Yoshikai

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

A CD30 ligand (CD30L, CD153) is a type II membrane-associated glycoprotein belonging to the TNF family. To illustrate the potential role of CD30L in CD4+ Th1 cell responses, we investigated the fate of Ag-specific CD4+ T cells in CD30L-deficient (CD30L-/-) mice after Mycobacterium bovis bacillus Calmette-Guérin (BCG) infection. The number of bacteria was significantly higher in organs of CD30L-/- mice than in wild-type (WT) mice 4 wk postinfection. The numbers of purified protein derivative-or Ag85B-specific-IFN-γ-producing-CD4+ T cells in spleen, lung, or peritoneal exudate cells were significantly fewer in CD30L -/- mice than in WT mice. During the infection, CD30L was expressed mainly by CD44+CD3+CD4+ T cells but not by CD3+CD8+ T cells, B cells, dendritic cells, or macrophages. Costimulation with agonistic anti-CD30 mAb or coculturing with CD30L-transfected P815 cells restored IFN-γ production by CD4+ T cells from BCG-infected CD30L-/- mice. Coculturing with CD30L +/+ CD4+ T cells from BCG-infected WT mice also restored the number of IFN-γ+CD30L-/-CD4+ T cells. When transferred into the CD30L+/+ mice, Ag-specific donor CD30L-/- CD4+ T cells capable of producing IFN-γ were restored to the compared level seen in CD30L+/+ CD4+ T cells on day 10 after BCG infection. When naive CD30L+/+ T cells were transferred into CD30L-/- mice, IFN-γ-producing-CD4 + Th1 cells of donor origin were normally generated following BCG infection, and IFN-γ-producing-CD30L-/-CD4+ Th1 cells of host origin were partly restored. These results suggest that CD30L/CD30 signaling executed by CD30+ T-CD30L+ T cell interaction partly play a critical role in augmentation of Th1 response capable of producing IFN-γ against BCG infection.

Original languageEnglish
Pages (from-to)6316-6327
Number of pages12
JournalJournal of Immunology
Volume181
Issue number9
StatePublished - Nov 1 2008
Externally publishedYes

Fingerprint

Cell Communication
T-Lymphocytes
Infection
Bacillus
Th1 Cells
CD30 Ligand
Membrane Glycoproteins
Exudates and Transudates
Mycobacterium bovis
Dendritic Cells
B-Lymphocytes
Spleen
Macrophages
Bacteria
Lung

ASJC Scopus subject areas

  • Immunology
  • Medicine(all)

Cite this

Tang, C., Yamada, H., Shibata, K., Muta, H., Wajjwalku, W., Podack, E. R., & Yoshikai, Y. (2008). A novel role of CD30L/CD30 signaling by T-T cell interaction in Th1 response against mycobacterial infection. Journal of Immunology, 181(9), 6316-6327.

A novel role of CD30L/CD30 signaling by T-T cell interaction in Th1 response against mycobacterial infection. / Tang, Ce; Yamada, Hisakata; Shibata, Kensuke; Muta, Hiromi; Wajjwalku, Worawidh; Podack, Eckhard R.; Yoshikai, Yasunobu.

In: Journal of Immunology, Vol. 181, No. 9, 01.11.2008, p. 6316-6327.

Research output: Contribution to journalArticle

Tang, C, Yamada, H, Shibata, K, Muta, H, Wajjwalku, W, Podack, ER & Yoshikai, Y 2008, 'A novel role of CD30L/CD30 signaling by T-T cell interaction in Th1 response against mycobacterial infection', Journal of Immunology, vol. 181, no. 9, pp. 6316-6327.
Tang C, Yamada H, Shibata K, Muta H, Wajjwalku W, Podack ER et al. A novel role of CD30L/CD30 signaling by T-T cell interaction in Th1 response against mycobacterial infection. Journal of Immunology. 2008 Nov 1;181(9):6316-6327.
Tang, Ce ; Yamada, Hisakata ; Shibata, Kensuke ; Muta, Hiromi ; Wajjwalku, Worawidh ; Podack, Eckhard R. ; Yoshikai, Yasunobu. / A novel role of CD30L/CD30 signaling by T-T cell interaction in Th1 response against mycobacterial infection. In: Journal of Immunology. 2008 ; Vol. 181, No. 9. pp. 6316-6327.
@article{0cbcfce37fb444aea68a53bfd6449b06,
title = "A novel role of CD30L/CD30 signaling by T-T cell interaction in Th1 response against mycobacterial infection",
abstract = "A CD30 ligand (CD30L, CD153) is a type II membrane-associated glycoprotein belonging to the TNF family. To illustrate the potential role of CD30L in CD4+ Th1 cell responses, we investigated the fate of Ag-specific CD4+ T cells in CD30L-deficient (CD30L-/-) mice after Mycobacterium bovis bacillus Calmette-Gu{\'e}rin (BCG) infection. The number of bacteria was significantly higher in organs of CD30L-/- mice than in wild-type (WT) mice 4 wk postinfection. The numbers of purified protein derivative-or Ag85B-specific-IFN-γ-producing-CD4+ T cells in spleen, lung, or peritoneal exudate cells were significantly fewer in CD30L -/- mice than in WT mice. During the infection, CD30L was expressed mainly by CD44+CD3+CD4+ T cells but not by CD3+CD8+ T cells, B cells, dendritic cells, or macrophages. Costimulation with agonistic anti-CD30 mAb or coculturing with CD30L-transfected P815 cells restored IFN-γ production by CD4+ T cells from BCG-infected CD30L-/- mice. Coculturing with CD30L +/+ CD4+ T cells from BCG-infected WT mice also restored the number of IFN-γ+CD30L-/-CD4+ T cells. When transferred into the CD30L+/+ mice, Ag-specific donor CD30L-/- CD4+ T cells capable of producing IFN-γ were restored to the compared level seen in CD30L+/+ CD4+ T cells on day 10 after BCG infection. When naive CD30L+/+ T cells were transferred into CD30L-/- mice, IFN-γ-producing-CD4 + Th1 cells of donor origin were normally generated following BCG infection, and IFN-γ-producing-CD30L-/-CD4+ Th1 cells of host origin were partly restored. These results suggest that CD30L/CD30 signaling executed by CD30+ T-CD30L+ T cell interaction partly play a critical role in augmentation of Th1 response capable of producing IFN-γ against BCG infection.",
author = "Ce Tang and Hisakata Yamada and Kensuke Shibata and Hiromi Muta and Worawidh Wajjwalku and Podack, {Eckhard R.} and Yasunobu Yoshikai",
year = "2008",
month = "11",
day = "1",
language = "English",
volume = "181",
pages = "6316--6327",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "9",

}

TY - JOUR

T1 - A novel role of CD30L/CD30 signaling by T-T cell interaction in Th1 response against mycobacterial infection

AU - Tang, Ce

AU - Yamada, Hisakata

AU - Shibata, Kensuke

AU - Muta, Hiromi

AU - Wajjwalku, Worawidh

AU - Podack, Eckhard R.

AU - Yoshikai, Yasunobu

PY - 2008/11/1

Y1 - 2008/11/1

N2 - A CD30 ligand (CD30L, CD153) is a type II membrane-associated glycoprotein belonging to the TNF family. To illustrate the potential role of CD30L in CD4+ Th1 cell responses, we investigated the fate of Ag-specific CD4+ T cells in CD30L-deficient (CD30L-/-) mice after Mycobacterium bovis bacillus Calmette-Guérin (BCG) infection. The number of bacteria was significantly higher in organs of CD30L-/- mice than in wild-type (WT) mice 4 wk postinfection. The numbers of purified protein derivative-or Ag85B-specific-IFN-γ-producing-CD4+ T cells in spleen, lung, or peritoneal exudate cells were significantly fewer in CD30L -/- mice than in WT mice. During the infection, CD30L was expressed mainly by CD44+CD3+CD4+ T cells but not by CD3+CD8+ T cells, B cells, dendritic cells, or macrophages. Costimulation with agonistic anti-CD30 mAb or coculturing with CD30L-transfected P815 cells restored IFN-γ production by CD4+ T cells from BCG-infected CD30L-/- mice. Coculturing with CD30L +/+ CD4+ T cells from BCG-infected WT mice also restored the number of IFN-γ+CD30L-/-CD4+ T cells. When transferred into the CD30L+/+ mice, Ag-specific donor CD30L-/- CD4+ T cells capable of producing IFN-γ were restored to the compared level seen in CD30L+/+ CD4+ T cells on day 10 after BCG infection. When naive CD30L+/+ T cells were transferred into CD30L-/- mice, IFN-γ-producing-CD4 + Th1 cells of donor origin were normally generated following BCG infection, and IFN-γ-producing-CD30L-/-CD4+ Th1 cells of host origin were partly restored. These results suggest that CD30L/CD30 signaling executed by CD30+ T-CD30L+ T cell interaction partly play a critical role in augmentation of Th1 response capable of producing IFN-γ against BCG infection.

AB - A CD30 ligand (CD30L, CD153) is a type II membrane-associated glycoprotein belonging to the TNF family. To illustrate the potential role of CD30L in CD4+ Th1 cell responses, we investigated the fate of Ag-specific CD4+ T cells in CD30L-deficient (CD30L-/-) mice after Mycobacterium bovis bacillus Calmette-Guérin (BCG) infection. The number of bacteria was significantly higher in organs of CD30L-/- mice than in wild-type (WT) mice 4 wk postinfection. The numbers of purified protein derivative-or Ag85B-specific-IFN-γ-producing-CD4+ T cells in spleen, lung, or peritoneal exudate cells were significantly fewer in CD30L -/- mice than in WT mice. During the infection, CD30L was expressed mainly by CD44+CD3+CD4+ T cells but not by CD3+CD8+ T cells, B cells, dendritic cells, or macrophages. Costimulation with agonistic anti-CD30 mAb or coculturing with CD30L-transfected P815 cells restored IFN-γ production by CD4+ T cells from BCG-infected CD30L-/- mice. Coculturing with CD30L +/+ CD4+ T cells from BCG-infected WT mice also restored the number of IFN-γ+CD30L-/-CD4+ T cells. When transferred into the CD30L+/+ mice, Ag-specific donor CD30L-/- CD4+ T cells capable of producing IFN-γ were restored to the compared level seen in CD30L+/+ CD4+ T cells on day 10 after BCG infection. When naive CD30L+/+ T cells were transferred into CD30L-/- mice, IFN-γ-producing-CD4 + Th1 cells of donor origin were normally generated following BCG infection, and IFN-γ-producing-CD30L-/-CD4+ Th1 cells of host origin were partly restored. These results suggest that CD30L/CD30 signaling executed by CD30+ T-CD30L+ T cell interaction partly play a critical role in augmentation of Th1 response capable of producing IFN-γ against BCG infection.

UR - http://www.scopus.com/inward/record.url?scp=58749085066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58749085066&partnerID=8YFLogxK

M3 - Article

C2 - 18941223

AN - SCOPUS:58749085066

VL - 181

SP - 6316

EP - 6327

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 9

ER -